$RGBP The company is currently developing small m
Post# of 6702
Posted On: 09/20/2016 10:37:02 AM
$RGBP The company is currently developing small molecule drugs that target NR2F6 and either inhibit production of these factors or, in other cases, stimulate their production. The goal is to have a series of compounds that can modulate the immune system up or down.
http://tinyurl.com/ztyofyj
$RGBPP #biotech #houseofrespect #jobs #pharma #stocktip #job #science #ipo #goog #googl #AMGN #BIIB #CELG #GILD #REGN #VRTX #MYL
http://tinyurl.com/ztyofyj
$RGBPP #biotech #houseofrespect #jobs #pharma #stocktip #job #science #ipo #goog #googl #AMGN #BIIB #CELG #GILD #REGN #VRTX #MYL
(0)
(0)
Consider all my posts my opinion and not advice to buy or sell anything. I post on stocks I own or am considering owning. Do your own DD!
Scroll down for more posts ▼